Key result
IV insulin and anticoagulation yield ~95% triglyceride reduction in severe hypertriglyceridemia.
Why the study?
The coexistence of diabetic ketoacidosis, severe hypertriglyceridemia, acute pancreatitis, and splenic vein thrombosis represents an exceptionally rare clinical presentation.
Does multidisciplinary management including insulin and anticoagulation improve outcomes in a patient with DKA, severe HTG, acute pancreatitis, and splenic vein thrombosis?
Case Report (n=1)
No
Does multidisciplinary management including insulin and anticoagulation improve outcomes in a patient with DKA, severe HTG, acute pancreatitis, and splenic vein thrombosis?
This case highlights a rare clinical tetrad of DKA, severe hypertriglyceridemia, acute pancreatitis, and splenic vein thrombosis, successfully managed with insulin and anticoagulation.
Multidisciplinary insulin-anticoagulation management was associated with improvement in this tetrad; leaves open need for prospective validation.
Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency that may be accompanied by severe hypertriglyceridemia (HTG), particularly in patients with poorly controlled type 1 or 2 diabetes mellitus. Marked HTG is a well-recognized cause of acute pancreatitis, while splenic vein thrombosis (SVT) is an uncommon vascular complication of pancreatic inflammation. The coexistence of these four conditions represents an exceptionally rare clinical presentation. SVT is clinically significant, as it may cause sinistral portal hypertension, gastric varices, and gastrointestinal bleeding. A 34-year-old man with type 2 diabetes mellitus presented with abdominal pain, nausea, vomiting, and DKA. Initial evaluation revealed severe HTG and HTG-induced acute pancreatitis (HTG-AP), with CT showing a bulky, ill-defined pancreas, peripancreatic fluid, and fat stranding. He was initially treated with intravenous insulin, aggressive fluid resuscitation, and electrolyte replacement. Persistent abdominal pain prompted repeat CT on hospital day 3, which demonstrated isolated SVT with perigastric collaterals and no portal or superior mesenteric vein involvement. Therapeutic intravenous heparin was initiated, followed by transition to oral apixaban. He was discharged in stable condition on basal-bolus insulin, atorvastatin, fenofibrate, and omega-3 acid ethyl esters with multidisciplinary follow-up. This case describes a rare clinical tetrad linking DKA, severe HTG, HTG-AP, and SVT. It highlights the importance of early recognition and prompt multidisciplinary management of both the metabolic and thrombotic complications associated with this uncommon presentation.
No takes yet. Share an insight, caveat, or question.
Adetiloye et al. (2026) conducted a case report in Diabetic ketoacidosis, severe hypertriglyceridemia, acute pancreatitis, and splenic vein thrombosis (n=1). Intravenous insulin and anticoagulation was evaluated on Clinical improvement and triglyceride reduction. Multidisciplinary management with intravenous insulin and anticoagulation led to clinical improvement and a reduction in triglycerides from 6362 mg/dL to 315 mg/dL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: